DVT/PE Treatment Enters New Era
By Chris Kaiser, Cardiology Editor, MedPage Today
Published: January 14, 2013
"The new class of oral anticoagulants that includes rivaroxaban (Xarelto) has the potential to radically alter practice patterns for treating and managing venous thromboembolism (VTE).
..."The availability of rivaroxaban for DVT has the potential to keep people who come into the emergency room out of the hospital," said Jack Hansel, MD, a hematologist and chairman of the department of medicine at Lenox Hill Hospital in New York City.
It could make the entire patient encounter in the ER shorter, potentially ease ER overcrowding, and free up some "much needed beds," he added. In addition, patients with an uncomplicated PE can be treated with rivaroxaban and discharged home."
*
RISK FOR A DVT BLOOD CLOTH
(From PreventDVT.org The Coalition to Prevent Deep-Vein Thrombosis)